Comparison of Analgesic efficacy of continuous adductor canal block with and without IPACK block for postoperative analgesia in patients undergoing total knee replacement.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/01/049329

Enrollment

Registered

2023-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Continuous Adductor Canal block with IPACK block.: Patients will receive 20 ml of 0.125% levobupivacaine+100 mcg dexmedetomidine for adductor canal block and 10 ml 0.125% levobupivacain

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status 1-2 Age 16-65 BMI 18-30 kg/m2 Unilateral Total Knee Replacement for osteoarthritis

Exclusion criteria

Exclusion criteria: Patient refusing to give informed consent. History of relevant drug allergy History of psychiatric illness, substance abuse Severe cardiovascular, respiratory , metabolic or neurological disease Pregnancy and lactation Cogaulopathy Infection at planned injection site Patient on steroids

Design outcomes

Primary

Measure	Time frame
Analgesic efficiency of anaesthetic modalities in terms of NRS.Timepoint: 4,12,24,36 and 48 hrs after administering the block	—

Secondary

Measure	Time frame
Total 48 hr consumption of 0.125% levobupivacaine(in ml)by patient controlled regional analgesia Sensory and Motor blockade Patient satisfaction Length of hospital stay Side effectsTimepoint: Time of administration of nerve block to 48 hrs .	—

Countries

India

Contacts

Public ContactDr Sukanya Mitra

Government Medical College and Hospital, Sector 32,Chandigarh

drsmitra12@yahoo.com9646121521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026